First Tracks Biotherapeutics, Inc. (TRAX)
Healthcare
Biotechnology
—
46.20 $
+4.8%
vs. previous close
Closing price · As of: 3. Aug 2026
First Tracks Biotherapeutics, Inc. (TRAX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 331 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | 2023 | 2024 | 2025 |
|---|---|---|---|
| 444 | 442 | 331 | |
| 399 | 390 | 316 | |
| 36 | 123 | 238 | |
| 391 | 385 | 312 | |
| 34 | 50 | 43 | |
| 18 | 36 | 31 | |
| 1.8 | 1.9 | 2.1 | |
| 2.4 | 3.8 | 3.1 | |
| 410 | 392 | 287 | |
| 35 | 35 | – |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.